A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders

By Whiteley Paul   Haracopos Demetrious   Knivsberg Ann-Mari   Reichelt Karl Ludvig   Parlar Sarah   Jacobsen Judith   Seim Anders   Pedersen Lennart   Schondel Maja   Shattock Paul  

Nutritional Neuroscience, Vol. 13, Iss. 2, 2010-04 ,pp. : 87-100

Maney Publishing

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

By Beghi E.   Gatti G.   Tonini C.   Ben-Menachem E.   Chadwick D.W.   Nikanorova M.   Gromov S.A.   Smith P.E.M.   Specchio L.M.   Perucca E.   on behalf of BASE Study Group  

Epilepsy Research, Vol. 57, Iss. 1, 2003-11 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

By Schwartz Thomas   Azhar Nouman   Husain Juhi   Nihalani Nikhil   Simionescu Mihai   Coovert Douglas   Jindal Shefali   Tirmazi Syed  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 3, 2005-07 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite